Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor
- 1 December 2006
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 84 (12) , 1251-1258
Abstract
Breast cancer resistance protein, BCRP, is a multidrug resistance protein that is highly expressed in the human placenta. In cancer tissues, this protein actively extrudes a wide variety of chemically and structurally unrelated chemotherapeutic drugs and other compounds. Studies in mice have shown that in the absence of BCRP activity in the placenta, there is a 2-fold increase in the uptake in BCRP substrates into fetus. This suggests that in the placenta, BCRP extrudes compounds that would otherwise cross the syncytiotrophoblast cells into fetal circulation. The purpose of this study was to examine the expression and localization of BCRP in the human placenta throughout gestation. Tissues from 6–13, 16–19, 24–29, 32–35, and 38–41 weeks of gestation were used. Real time RT-PCR analysis demonstrated that the mRNA levels of BCRP in the placenta do not change significantly as gestation progressed. However, Western blot analysis revealed that the protein levels increased towards the end of gestation. We demonstrated that BCRP is localized to the syncytiotrophoblast of the placenta and in some fetal blood vessels within the placenta. Tissues from the early stages of pregnancy (6–13 weeks) showed fewer BCRP positive blood vessels than term tissues (38–41 weeks).Keywords
This publication has 22 references indexed in Scilit:
- ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblastAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Complement-Mediated Mechanisms in Anti-GD2 Monoclonal Antibody Therapy of Murine Metastatic CancerCancer Research, 2005
- Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) ExpressionJournal of Biological Chemistry, 2004
- Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein ( ABCG2 ) GeneCancer Research, 2004
- Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactisJournal of Biological Chemistry, 2003
- Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1)Cancer Biology & Therapy, 2002
- Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded materialThe Journal of Pathology, 2002
- The Human ATP-Binding Cassette (ABC) Transporter SuperfamilyGenome Research, 2001
- Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of TopotecanJNCI: Journal of the National Cancer Institute, 2000
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998